MSL1 (NM_001012241) Human Recombinant Protein
CAT#: TP761674
Purified recombinant protein of Human male-specific lethal 1 homolog (Drosophila) (MSL1), full length, with N-terminal HIS tag, expressed in E. coli, 50ug
View other "MSL1" proteins (2)
|
Need it in bulk or customized? Get a free quote |
CNY 2040.00
货期*
现货
规格
推荐一起购买 (1)
Specifications
| Product Data | |
| Species | Human |
| Expression Host | E. coli |
| Expression cDNA Clone or AA Sequence |
A DNA sequence encoding human full-length MSL1
|
| Tag | N-His |
| Predicted MW | 40.6 kDa |
| Concentration | >0.05 µg/µL as determined by microplate BCA method |
| Purity | > 80% as determined by SDS-PAGE and Coomassie blue staining |
| Buffer | 50 mM Tris-HCl, pH 8.0, 8 M urea |
| Note | For testing in cell culture applications, please filter before use. Note that you may experience some loss of protein during the filtration process. |
| Storage | Store at -80°C. |
| Stability | Stable for 12 months from the date of receipt of the product under proper storage and handling conditions. Avoid repeated freeze-thaw cycles. |
| Reference Data | |
| RefSeq | NP_001012241 |
| Locus ID | 339287 |
| UniProt ID | Q68DK7 |
| Refseq Size | 3834 |
| Cytogenetics | 17q21.1 |
| Refseq ORF | 1053 |
| Synonyms | MSL-1 |
| Summary | Component of histone acetyltransferase complex responsible for the majority of histone H4 acetylation at 'Lys-16' (H4K16ac) which is implicated in the formation of higher-order chromatin structure (PubMed:16227571). Greatly enhances MSL2 E3 ubiquitin ligase activity, promoting monoubiquitination of histone H2B at 'Lys-34' (H2BK34Ub) (PubMed:21726816). This modification in turn stimulates histone H3 methylation at 'Lys-4' (H3K4me) and 'Lys-79' (H3K79me) and leads to gene activation, including that of HOXA9 and MEIS1 (PubMed:21726816). In the MSL complex, acts as a scaffold to tether MSL3 and KAT8 together for enzymatic activity regulation (PubMed:22547026).[UniProtKB/Swiss-Prot Function] |
Documents
| FAQs |
| SDS |
Resources
| 蛋白相关资源 |
Customer
Reviews
Loading...
